Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 242

1.

Anion Effects in Oxidative Aliphatic Carbon-Carbon Bond Cleavage Reactions of Cu(II) Chlorodiketonate Complexes.

Saraf SL, Miłaczewska A, Borowski T, James CD, Tierney DL, Popova M, Arif AM, Berreau LM.

Inorg Chem. 2016 Jul 18;55(14):6916-28. doi: 10.1021/acs.inorgchem.6b00456. Epub 2016 Jul 5.

PMID:
27377103
2.

Single objective light-sheet microscopy for high-speed whole-cell 3D super-resolution.

Meddens MB, Liu S, Finnegan PS, Edwards TL, James CD, Lidke KA.

Biomed Opt Express. 2016 May 17;7(6):2219-36. doi: 10.1364/BOE.7.002219. eCollection 2016 Jun 1.

3.

Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.

Hashizume R, Zhang A, Mueller S, Prados MD, Lulla RR, Goldman S, Saratsis AM, Mazar AP, Stegh AH, Cheng SY, Horbinski C, Haas-Kogan DA, Sarkaria JN, Waldman T, James CD.

Neuro Oncol. 2016 Jul 1. pii: now106. [Epub ahead of print]

PMID:
27370397
4.

MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.

Bell JB, Eckerdt F, Alley K, Magnusson LP, Hussain H, Bi Y, Arslan AD, Clymer J, Alvarez AA, Goldman S, Cheng SY, Nakano I, Horbinski C, Davuluri RV, James CD, Platanias LC.

Mol Cancer Res. 2016 Jun 30. pii: molcanres.0172.2016. [Epub ahead of print]

PMID:
27364770
5.

BRAF status in personalizing treatment approaches for pediatric gliomas.

Olow A, Mueller S, Yang X, Hashizume R, Meyerowitz J, Weiss WA, Resnick AC, Waanders AJ, Stalpers LJ, Berger MS, Gupta N, James CD, Petritsch CK, Haas-Kogan DA.

Clin Cancer Res. 2016 May 23. pii: clincanres.1101.2015. [Epub ahead of print]

PMID:
27217440
6.

Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma.

Wei W, Shin YS, Xue M, Matsutani T, Masui K, Yang H, Ikegami S, Gu Y, Herrmann K, Johnson D, Ding X, Hwang K, Kim J, Zhou J, Su Y, Li X, Bonetti B, Chopra R, James CD, Cavenee WK, Cloughesy TF, Mischel PS, Heath JR, Gini B.

Cancer Cell. 2016 Apr 11;29(4):563-73. doi: 10.1016/j.ccell.2016.03.012.

PMID:
27070703
7.

Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?

James CD, Roberts S.

Pathogens. 2016 Jan 18;5(1). pii: E8. doi: 10.3390/pathogens5010008. Review.

8.

Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.

Dasgupta T, Olow AK, Yang X, Hashizume R, Nicolaides TP, Tom M, Aoki Y, Berger MS, Weiss WA, Stalpers LJ, Prados M, James CD, Mueller S, Haas-Kogan DA.

J Neurooncol. 2016 Feb;126(3):395. doi: 10.1007/s11060-015-2024-6. No abstract available.

PMID:
26782702
9.

Energy Scaling Advantages of Resistive Memory Crossbar Based Computation and Its Application to Sparse Coding.

Agarwal S, Quach TT, Parekh O, Hsia AH, DeBenedictis EP, James CD, Marinella MJ, Aimone JB.

Front Neurosci. 2016 Jan 6;9:484. doi: 10.3389/fnins.2015.00484. eCollection 2015.

10.

Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells.

Lerner RG, Grossauer S, Kadkhodaei B, Meyers I, Sidorov M, Koeck K, Hashizume R, Ozawa T, Phillips JJ, Berger MS, Nicolaides T, James CD, Petritsch CK.

Cancer Res. 2015 Dec 15;75(24):5355-66. doi: 10.1158/0008-5472.CAN-14-3689. Epub 2015 Nov 16.

PMID:
26573800
11.

Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.

Dasgupta T, Olow AK, Yang X, Hashizume R, Nicolaides TP, Tom M, Aoki Y, Berger MS, Weiss WA, Stalpers LJ, Prados M, James CD, Mueller S, Haas-Kogan DA.

J Neurooncol. 2016 Feb;126(3):385-93. doi: 10.1007/s11060-015-1939-2. Epub 2015 Sep 18. Erratum in: J Neurooncol. 2016 Feb;126(3):395.

PMID:
26384810
12.

EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.

Huang X, He Y, Dubuc AM, Hashizume R, Zhang W, Reimand J, Yang H, Wang TA, Stehbens SJ, Younger S, Barshow S, Zhu S, Cooper MK, Peacock J, Ramaswamy V, Garzia L, Wu X, Remke M, Forester CM, Kim CC, Weiss WA, James CD, Shuman MA, Bader GD, Mueller S, Taylor MD, Jan YN, Jan LY.

Nat Neurosci. 2015 Sep;18(9):1236-46. doi: 10.1038/nn.4088. Epub 2015 Aug 10.

13.

EGFR blockade prevents glioma escape from BRAFV600E targeted therapy.

Yao TW, Zhang J, Prados M, Weiss WA, James CD, Nicolaides T.

Oncotarget. 2015 Sep 8;6(26):21993-2005.

14.

Induction frequency affects cortico-striatal synaptic plasticity with implications for frequency filtering.

Baca M, Schiess AR, Jelenik D, James CD, Donald Partridge L.

Brain Res. 2015 Jul 30;1615:80-8. doi: 10.1016/j.brainres.2015.04.031. Epub 2015 Apr 23.

PMID:
25912436
15.

The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.

Siddiqa A, Léon KC, James CD, Bhatti MF, Roberts S, Parish JL.

J Gen Virol. 2015 Aug;96(8):2274-85. doi: 10.1099/vir.0.000162. Epub 2015 Apr 24.

16.

miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.

Kouri FM, Hurley LA, Daniel WL, Day ES, Hua Y, Hao L, Peng CY, Merkel TJ, Queisser MA, Ritner C, Zhang H, James CD, Sznajder JI, Chin L, Giljohann DA, Kessler JA, Peter ME, Mirkin CA, Stegh AH.

Genes Dev. 2015 Apr 1;29(7):732-45. doi: 10.1101/gad.257394.114.

17.

Challenges in EGFRvIII detection in head and neck squamous cell carcinoma.

Wheeler SE, Egloff AM, Wang L, James CD, Hammerman PS, Grandis JR.

PLoS One. 2015 Feb 6;10(2):e0117781. doi: 10.1371/journal.pone.0117781. eCollection 2015.

18.

Radiotherapy followed by aurora kinase inhibition targets tumor-propagating cells in human glioblastoma.

Li N, Maly DJ, Chanthery YH, Sirkis DW, Nakamura JL, Berger MS, James CD, Shokat KM, Weiss WA, Persson AI.

Mol Cancer Ther. 2015 Feb;14(2):419-28. doi: 10.1158/1535-7163.MCT-14-0526. Epub 2014 Dec 18.

19.

Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor α.

Feng H, Li Y, Yin Y, Zhang W, Hou Y, Zhang L, Li Z, Xie B, Gao WQ, Sarkaria JN, Raizer JJ, James CD, Parsa AT, Hu B, Cheng SY.

Neuro Oncol. 2015 Jun;17(6):832-42. doi: 10.1093/neuonc/nou323. Epub 2014 Dec 2.

20.

Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells.

Clark AJ, Safaee M, Oh T, Ivan ME, Parimi V, Hashizume R, Ozawa T, James CD, Bloch O, Parsa AT.

J Transl Med. 2014 Dec 3;12:345. doi: 10.1186/s12967-014-0345-4.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk